Q3 2012
Released Oct 26, 2012, after the close
10-Q filed Oct 26, 2012, 26 days after period end · 0001558891-12-000025
Q3 2012 · 10-Q
Revenue$0.00$0.00 — vs Q3 2011no prior Q2 2012 on file
Net Income-$1.01M-$1.01M — vs Q3 2011N/M vs Q2 2012
EPS Diluted-$0.23-$0.23 — vs Q3 2011no prior Q2 2012 on file
Operating Income-$1,015,001—
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2012 | Q3 2011 |
|---|---|---|
| Revenue | $0.00 | $0.00 |
| Net Income | -$1.01M | $0.00 |
| EPS Diluted | -$0.23 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR